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Abstract: The possibility that clathrin plays a role in the
agonist-mediated sequestration of muscarinic cholinergic
receptors in human SH-SY5Y neuroblastoma cells has
been investigated by the application of experimental par-
adigms previously established to perturb clathrin distribu-
tion and receptor cycling events. Preincubation of SH-
SY5Y cells under hypertonic conditions resulted in a pro-
nounced inhibition of agonist-induced muscarinic recep-
tor sequestration (70—80% at 550 mOsm), which was
reversed when cells were returned to isotonic medium.
Depletion of intracellular K + oracidification of the cytosol
also resulted in >80% inhibition of muscarinic receptor
sequestration. Under conditions of hypertonicity, deple-
tion of intracellular KT, or acidification of cytosol, musca-rinic receptor-stimulated phosphoinositide hydrolysis
and Ca2~signaling events were either unaffected or
markedly less inhibited than receptor sequestration. That
these same experimental conditions did perturb clathrin
distribution was verified by immunofluorescence studies.
Hypertonicity and depletion of intracellular KT resulted in
a pronounced accumulation of clathrin in the perinuclear
region, whereas acidification of the cytosol resulted in the
appearance of microaggregates of clathrin throughout
the cytoplasm and at the plasma membrane. The results
are consistent with the possibility that muscarinic recep-
tors in SH-SY5Y cells are endocytosed via a clathrin-
dependent mechanism. Key Words: Phosphoinositide
hydrolysis—Ca24 signaling—Caveolae— Hyperosmolar-
ity—Depletion of intracellular K~—Receptor endocy-
tosis.
tor fromeffectorenzyme(ThompsonandFisher, 1991;
Fisher, 1995),dephosphorylationof cell surfacerecep-
tors (Yu eta!.,1993),or anobligatoryprecursorevent
in receptordown-regulation(Thompsonand Fisher,
1990; but see a!so Hausdorffet al., 1990). Further-
more, therehasbeensome controversyasto whether
sequesteredreceptorsaretruly endocytosedinto acyto-
plasmiccompartment,as indicatedfrom studiesof the
agonist-inducedsubcellularredistributionof receptors
(Hardenet a!., 1985), or whetherchangesin radioli-
gand binding reflect morean a!teredconformationof
the receptorwithin the sameplasmamembraneloca-




tion favors the hypothesisthat cell surfacereceptors
undergoendocytosis(vonZastrowandKobilka, 1992).
Evidencefor a colocalization of the internalized /32-
adrenergic receptor with the transferrin receptor
(whichis endocytosedvia a c!athrin-coatedpit mecha-
nism) has beenobtained from immunocytochemical
studies (vonZastrow and Kobilka, 1992). However,
whethertheendocytosed/32-adrenergicreceptorsorigi-
nate in clathrin-coatedpits or, alternatively,in non—
clathrin-coatedmembraneinvaginations,e.g.,caveolae
(seeAnderson,1993),remainsuncertain.In addition,
thereis currently little mechanisticinformation regard-
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Prolongedagonistoccupancyof eitheradenylyl cy-
clase or phosphoinositide-specificphospholipaseC
(PLC ) -linked receptorsresultsin anadaptiveresponse
in which cell surfacereceptorsare internalized(se-
questered)and therebybecomeless accessibleto by-
drophilic ligands. Althoughreceptorsequestrationhas
been frequently documented,neither the underlying
moleculareventsnor the precisephysiologicalsignifi-
cancehas beenestablished.In the latter context,sev-
eralpossibilitiesexist, suchasuncouplingof therecep-
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2~l,, cytoplasmic C 2~
c ncentration;1(l,4,5)P
3, inositol 1,4,5-trisphosphate;‘PT, total
inositol phosphatefraction; K
T,, intracellularK~mAChR, musca-
rinic cholinergic receptor; NMS, N-methylscopolamine;Oxo-M,
oxotremorine-M;PBS,phosphate-bufferedsaline;PLC, phosphoino-
sitide-speciflcphospholipaseC; PMA, phorbol 12-myristate13-ace-
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ing the endocytosisof otherG protein-coupledrecep-
tors, in particular those linked to PLC.
In the presentstudy,biochemicaland immunocyto-
chemical approacheshavebeenused to evaluatethe
role, if any, playedby clathrin in the agonist-mediated
sequestrationof muscarinic cholinergic receptors
(mAChRs) present in human SH-SY5Y neuro-
blastoma.Thesecells have beenpreviously demon-
stratedto expressa relativelyhighdensityof mAChRs
(20,000—30,000per cell) that are predominantly
~ 80%)of them3 subtypeandthatcoupleto phospho-
inositideturnover(Slowiejkoet al., 1994).Moreover,
thepresenceof clathrin hasbeendocumentedin these
cells (Sadéeet al., 1987).Thepresentresultsindicate
thatexperimentalproceduresthathavepreviouslybeen
demonstratedto perturb clathrin distribution and to
inhibit receptorendocytosisvia either the disruption
of formationof clathrin-coatedpits, e.g.,hypertonicity
or depletionof intracellular KT (K~~)(Larkin et al.,
1986; Heuserand Anderson, 1989) or, alternatively,
by preventionof thebuddingof coatedpits, e.g.,acidi-
fication of thecytosol(Sandviget al., 1987),all result
in a markedinhibition of agonist-mediatedmAChR
sequestrationin SH-SYSYcells. However, the ability
of mAChRs to coupleto PLC and secondmessenger
generationin SH-SY5Ycells is much less adversely
affected by these procedures. Immunocytochemical
studiesindicatethata cellularredistributionof clathrin
accompaniesthe observedattenuationof mAChR se-
questration.Theresultssuggesthatupon agonistaddi-
tion, mAChRsin SH-SY5Y cells are endocytosedvia
a clathrin-linked mechanism.A preliminary account
of partof this work haspreviouslybeenreported(Sb-
wiejko et al., 1995).
MATERIALS AND METHODS
myo-[2-
3H] Inositol (102 Ci!mmol), [N-methyl- 3H1-
scopolaminemethyl chloride ([3H]NMS; 87 Ci/mmol),




chased from Amersham Corp. (Arlington Heights, IL,
U.S.A.). [3H]Quinuclidinyl benzilate([3H]QNB; 45.4 Ci!
mmol) wasobtainedfrom New EnglandNuclear (Boston,
MA, U.S.A.).Atropine, pilocarpine,NMS, phorbol 12-my-
ristate 13-acetate(PMA), digitonin, filipin, nigericin, and
nystatinwereobtainedfrom SigmaChemicalCo.(St. Louis,
MO, U.S.A.). Oxotremorine-M (Oxo-M) was purchased
from ResearchBiochemicals International (Natick, MA,
U.S.A.). Fura-2 acetoxymethylester, 2,7-biscarboxyethyl-
5(6)-carboxyfluoresceinacetoxymethyl ester (BCECF-
AM), and anti-fluoresceinrabbit IgG wereobtainedfrom
Molecular Probes (Eugene,OR, U.S.A.). I(1,4,5)P
3 and
concanavalin A were purchasedfrom Calbiochem (San
Diego,CA, U.S.A.).Pepstatin,leupeptin,aprotinin,andPef-





IgG was obtainedfrom Vector Laboratories(Burlingame,
CA, U.S.A.). Tissueculture supplieswere purchasedfrom
Corning GlassWorks (Corning, NY, U.S.A.). Powdered
Dulbecco’smodified Eagle’smedium and fetal calf serum
wereobtainedfrom GIBCO (Grand Island, NY, U.S.A.).
HumanSH-SY5Y neuroblastomacells were obtainedfrom
Dr. JuneBiedler (SloanKetteringInstitute,New York, NY,
U.S.A.). Monoclonalanti-clathrinheavychain antibody(X-
22) wasagenerousgift from Dr. FrancesBrodsky(Univer-




routinely grown in tissuecultureflasks(75 cm
2!250ml) in
20 ml of Dulbecco’smodifiedEag e’smediumsupplemented
with 10% (by volume) fetal calf serum.Cells were grown
for 7—14 daysat 37°Cin an atmosphereconsistingof 10%
CO
2 and90% humidifiedair. Cellswere isolatedafteraspira-
tion of the mediumandincubationwith a modified Pucks
D1 solution (HoneggerandRichelson,1976). For immuno-
cytochemicalstudies,SH-SYSYcells were grown on glass
coverslips(22mm in diameter)for 48 h, duringwhich time
20—30%confluencywasachieved.
Subcellular fractionation
A modified procedureof the method of Straderet al.
(1984)wasused.Ten to 20 flasksof SH-SY5Y cells were
detachedand resuspendedin buffer A (142 mM NaCI, 5.6
mM KCI, 2.2 mM CaCI2,3.6 mM NaHCO3, 1 mM MgC12,
5.6mM D-glucose,and 30 mM HEPES,pH 7.4),and 5-ml
aliquotsof cells were incubatedfor 30 mm at 37°Cin the
presenceor absenceof agonistunder the conditionsdefined
(hypertonicity,K ~ depletion,etc.). Reactionswere termi-
nated by addition of 30 ml of ice-coldbuffer A, andcells
were centrifugedat 300 g for 3 mm at 4°C.Supernatants
were aspirated,andcell pelletswere resuspendedin ice-cold
bufferA (—glucose)thatcontained2.5 mg/mIof concanava-
lin A. Cells wereleft on ice for 20 mm andrecentrifugedat
300 g for 3 mm. Cell pelletswerethen hypotonically lysed
by gentlehomogenizationin 10 ml of TE buffer [10 mM
Tris-HC1 (pH 7.4), 2 mM EDTA, 2 ~g/ml of aprotinin, I
~tg!ml of leupeptin,0.7 ~ag/mlof pepstatin,and1 mM Pef-
abloci. Lysateswere then centrifugedat 30,000 g for 10
mm to obtain acrudeplasmamembrane(P1) fraction. The
supernatantswere then centrifugedat 200,000g for 90 mm
to obtain a “light” membrane(V1) fraction.
Radioligand binding
Agonist-inducedsequestrationof mAChRswasmonitored
as the loss of [
3H]NMS binding sites on intact SH-SY5Y
cells, as previouslydescribed(ThompsonandFisher,1990;
Slowiejko et al., 1994). After exposureof cells to Oxo-M,
the agonistwasremovedby washing,and aliquotsof cells
were then incubatedwith either 6 nM [3HINMS in buffer
A for 18 h at 4°Cor, alternatively,with I nM [3H]QNB in
buffer A for 90 mm at 37°C.Subcellularfractionsof SH-
SY5Y cells were resuspendedin KGEH buffer (139 mM
potassiumglutamate,4 mM MgCI
2, 10 mM EGTA, and
30 mM HEPES,pH 7.4), a buffer that approximatesthe
intracellular milieu, before radioligandbinding. The low
temperatureusedfor [
3H]NMS assaysensuresthat therecy-
cling of mAChRst plasmamembraneis prevented(Thomp-
sonandFisher, 1991).Nonspecificbinding wasdetermined
asthatunaffectedby inclusionof 25 ~..tMatropine.Reactions
were rapidly terminatedby filtration throughWhatmanGF!
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B glassfiber filters, andradioactivity wasdeterminedafter
addition of 5 ml of Universol scintillation fluid.
Immunoprecipitation of mAChR subtypes
The proportion of mAChR subtypespresentin the V1
fraction was determinedby the procedurespreviously de-




Basal and Oxo-M-stimulatedvalues for [Ca2T]~in SH-
SYSY cells were determinedby monitoring fura-2 fluores-
cence in a Shimadzu model RF-5000 spectrofluorophoto-
meter using the dual wavelengthmethod, as previously de-
scribed(Thompsonet al., 1991).
Measurementof cytoplasmic pH
IntracellularpH wasmonitoredusing the membrane-per-
meantfluorescentprobe BCECF-AM (Rink et al., 1982).
Cell suspensionswere incubatedwith the probe (4
1.tM) in
buffer A for 30 mm at 37°C.The cells were then washed
free of the extracellularprobeand transferredto the cuvette
compartment of a dual wavelength computer-controlled
spectrofluorimeter(SPEX, Edison, NJ, U.S.A.). The fluo-
rescenceintensity was monitoredas the ratio of excitation
intensity at 505 nm relative to that at 439 nm (isobestic
point).Emissionwasmonitoredat 530nm. Theabsenceof
dye leakagewasconfirmedduring experimentsby addition
of an anti-fluoresceinrabbit IgG antibody to the cuvette.
Calmbrationof the intracellular fluoresceinspectrawasob-
tamnedby equilibratmonof theextracellularandintracellular




SH-SY5Y cells were allowed to prelabelfor 3 days in
Dulbecco’smodified Eagle’smedium/fetalcalf serumcon-
tamnmng 10 jiCm/ml of [
3H]ino itol. Cells werethendeta hed
andwashedwith buffer A. Following the experimentalma-
nipulations,the accumulationof atotal radiolabeledinositol
phosphatefraction (3H-IPT) observedin thepresenceor ab-
senceof 1 mM Oxo-M was monitoredduring a 30-mm





viously described(Palmeret al., 1994). Aliquots of SH-
SY5Y cells (‘—1 mg of protein) were incubatedin 0.5 ml
of buffer A at 37°Cin the presenceor absenceof 1 mM
Oxo-M. Reactionswereterminatedby additionof 0.5 ml of
ice-cold20%(wt!vol) trichloroaceticacid.Thetrichloroace-
tic acid extractswere first neutralizedwith water-saturated
diethyl ether.Aliquots of neutralizedextracts(Fisheret al.,
1990) were then incubatedin 10 mM Tris-HCI, 1 mM
EDTA, and0.! mM /3-mercaptoethanol(pH 8.8) for 15 mm
at 4°Cwith a rat cerebellarmembranepreparation(400 jig
of protein) in the presenceof 0.01 j.tCi of [
3H]I(l,4,5)P
3.
Standards[0—10 pmol of 1(1,4,5)P3] wereassayedconcur-
rently. Bound radioligandwasseparatedfrom free radioli-
gandby rapid vacuumfiltration (at 4°C)throughWhatman
GF/B glassfiber filters. Protein contentwasmeasuredby
the methodof GeigerandBessman(1972).
Immunofluorescence
Human SH-SY5Y neuroblastomacells were grown on
glasscoverslipsin six-well platesfor 48 h andthensubjected
to theexperimentalprotocolsindicatedin thefigure legends.
At the end of each experimentalprotocol, the cells were
fIxed for 30 mm at room temperaturein 3.5% (wt!vol)
paraformaldehyde in 0.1 M phosphate-buffered saline
(PBS),pH 7.4. Cells were rinsedwith PBS twice and then
washedfor 15 mm with 50 mM NH4C1 in PBS followed by
two additional washesin PBS.The cells were then perme-
abilized with 0.04% (wt!vol) saponinin PBS for 15 mm at
room temperatureandthen blockedwith 1% (wt/vol) bo-
vine serumalbuminin PBSfor 30 mm. Theprimaryantibody
wasappliedonto the coverslips(100 ,ul) at aconcentration
of 5 p.g!ml (anti-heavychain clathrin; X-22) andincubated
overnightat 4°C.After four washes(10 mm each)with PBS,
the cells wereincubatedwith 100 ,ul of goatanti-mouseIgG
conjugatedto indocarbocyanine(1:200) for 60 mm at room
temperature.Coverslipswere then washedfour times (10
mm each)andmountedon glassslideswith p-phenylenedia-
mine in 75% glycerol!25% PBS. Immunofluorescencewas
observedby conventionaland confocal fluorescencemicros-
copy (Bio-Rad model MRC 600) with an argon—krypton
laseranda tetramethylrhodaminefilter.
Data analysis
Results given are mean ~ SEM values for the number
(n) of separateexperimentsperformed.Student’stwo-tailed
testswereusedto evaluatethestatisticaldifferencesof the




The extent of agonist-inducedsequestrationof
mAChRsandof stimulatedphosphoinositidehydroly-
sis wasmonitoredunderisotonic (325 mOsm) or hy-
pertonicconditions (Fig. I). Incubationof SH-SY5Y
cells in buffer A madehypertonicby supplementation
with either sucroseor NaCI impairedmAChR seques-
tration asa function of osmolarity. For example,after
thecellshadbeenexposedto Oxo-M for 30 mm under
hypertonicconditions (550 mOsm), ~—~70—80%fewer
I
3H I NMS binding sites were lost from thecell surface
than from agonist-treatedcells incubatedin isotonic
bufferA. Although completeinhibition of mAChR se-
questrationwas observedat .—~65()mOsm, the lower
value of 550 mOsm was routinely used to minimize
any significantchangein cell volume (see,for exam-
ple, Bowen andMorgan, 1988). To determinetheef-
fectof anincreasein osmolarityon mAChR-stimulated
phosphoinositidehydrolysis, the accumulationof 3H-
IPT was monitoredover a 30-mm incubation period.
The mAChR-stimulatedinositol lipid hydrolysis was
muchless inhibited underhypertonicconditions than
wasreceptorsequestration(.—~20—25%at 550mOsm).
Becausetheactivationof mAChRs in SH-SYSY cells
elicits two kinetically distinct phasesof mAChR-slim-
ulatedphosphoinositidehydrolysis (Fisheretal., 1994;
Wojcikiewicz et al., 1994), theeffectof hypertonicity
on initial receptorresponseswasalsomonitored.When
J. Neurochem.,Vol. 66, No. 1, 1996
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FIG. 1. The ability of Oxo-M to induce a loss of [3H]NMS bindingsites is reduced under conditions of hyperosmolarity. SH-SY5Y
cells (—‘1 mg of protein) were preincubated at 37°Cfor 20 mm
in either buffer A alone (isotonic; 325 mOsm) or with buffer A
made hypertonic by addition of either sucrose (0) or NaCI (•)
at the osmolarity indicated. Osmolarity was determined using an
Osmette osmometer (Precision Systems, Sudbury, MA, U.S.A.).
To each group of cells was then added Oxo-M (final concentra-
tion, 1 mM), and reactions were allowed to proceed for a further
30 mm at 37°C. Reactions were terminated, and the amount of
[3H]NMSspecifically bound was then determined as described
in Materials and Methods. When incubated in isotonic buffer A
in the absence of agonist, specific [3HJNMSbinding was —300
fmol/mg of protein. Hypertonicity had no detectable effect on
[3HJNMSbinding in the absence of Oxo-M. In the presence of
Oxo-M, 30—40% of mAChRs were sequestered under isotonic
conditions (325 mOsm). Under the same experimental condi-
tions, the ability of Oxo-M to stimulate the formation of 3H-IPT
was determined under either conditions of isotonicity or hyperto-
nicity [sucrose(V)or NaCI (7)added]. Radioactivity associated
with the 3H-IPT fraction under basal and Oxo-M-stimulated con-
ditions was —15 and 240>< 1 ~3 dpm!mg of protein, respectively.
Hypertonicity had no effecton 3H-IPT formation under basal con-
ditions. For both [3H]NMSand 3H-IPT level measurements, re-
sults shown are from individual experiments, and lines represent
linear regression analyses. The arrows (—°) indicate the hyper-
tonic conditions chosen for subsequent experiments (550
mOsm).
1(1,4,5)P
3 formation wasmonitoredafter 10 s of ago-
nist addition,comparableincreaseswereobservedfor
cells incubatedin isotonicandhypertonic (550mOsm)
bufferA (Fig. 2A), whereasa small reductionin the
Oxo-M-mediatedrise in [Ca
2~], w s observedi hy-
pertonically treated cells,when comparedwith cells
incubatedunderisotonicconditions(‘—25%; Fig. 2B).
Takentogether, these resultsindicate that incubation
of SH-SY5Y cells inhypertonicbuffer A results in a
more pronouncedinhibition of mAChR sequestration
than of phosphoinositidehydrolysis, regardlessof
whether the latter is monitored under conditions of
acute orprolongedagonist exposure.
Kinetics of mAChR sequestration under
hypertonic conditions
When cells were incubatedin isotonic buffer A,
mAChR sequestrationwas time dependentwith the
onsetoccurringwithin 5 mm of Oxo-M addition,and
FIG. 2. Effect of hypertonicity on (A) basal and Oxo-M-stimu-
lated l(1,4,5)P
3 formation and (B) basal and Oxo-M-stimulated
rise in [Ca
2~],.SH-SY5Y cells were preincubated for 20 mm at
37°Cin either the presence of isotonic buffer A (LI) or buffer A
made hypertonic with sucrose (1J; 550 mOsm). Cells were then
incubated in the absence or presence of 1 mM Oxo-M, and
basal and stimulated concentrations of l(1,4,5)P
3 were deter-
mined after 10 s of agonist addition (A). In B, both basal and
maximal increases in [Ca
2~],observed in the presence of Oxo-
M were monitored. A maximal increase in [Ca2~],was observed
—10—15 s after Oxo-M addition. Data are mean ± SEM (bars)
values (n = 4 and 20 for l(1,4,5)P
3 level and [Ca
2~],measure-
ments, respectively). °p < 0.05 for difference from isotonic
value.
the maximal effect observedafter 30—60 mm (Fig.
3A). In contrast, little orno loss of [3H]NMS binding
sites wasobservedat anytimepointfor agonist-treated
cells when incubated in hypertonic buffer A (550
FIG. 3. Time course and reversibility of the inhibition of Oxo-M-
induced loss of [3H]NMSbinding sites observed under hyper-
tonic conditions. A: SH-SY5Y cells were preincubated for 20 mm
in either the presence of isotonic buffer A (0) or buffer A plus
sucrose (•; 550 mOsm). After the preincubation period, Oxo-M
(final concentration, 1 mM) was added to each set of incubation
mixtures, and reactions were allowed to proceed for the times
indicated. B: In a separate series of experiments, SH-SY5Y cells
were preincubated for 20 mm in either isotonic or hypertonic
buffer A, as detailed above. The hypertonically treated cells were
then divided into two aliquots, one of which was centrifuged and
resuspended in isotonic buffer A (Hyper —° iso), whereas the
other aliquot was resuspended in hypertonic buffer A and al-
lowed to incubate for 30 mm at 37°C.Oxo-M (1 mM) was then
added to each set of incubations, and reactions were allowed
to proceed for 30 mm at 37°C.Results for both A and B are mean
± SEM (bars) values for three or four separate experiments. *p
< 0.05 for difference from isotonic buffer A value.
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FIG. 4. Depletion of K~,or acidification of cytosol blocks ago-
nist-induced mAChR sequestration. A: SH-SY5Y cells (—1 mg
of protein) were premncubated for 40 (for depletion of K4,) or 10mm (for acidification of cytosol) in the absence or presence of
4 jiM nigericmn and in the presence of the [K4] and buffer A at
the pH values indicated. When the [K~] was increased to 142
mM, the [NaCI]was reduced to 5.5 mMto maintain isotonicity.
After premncubation, Oxo-M was added (final concentration, 1
mM), and reactions were allowed to proceed for a further 30
mi B: Cells prelabeled with [3H]inositolwere first preincubated
under conditions outlined above, and then the release of a 3H-
‘PT fraction was monitored in the presence of 1 mM Oxo-M
over a 30-mm incubation period. Values are expressed as
IPT formation relative to controls (incubated in the absence of
nigericmn). In the absence of the ionophore, values for both basal
and Oxo-M-stimuled 3H-IPT formation obtained in the presence
ofeither high [KT] or low pH were comparable to those observed
in the presence of buffer A (pH 7.4). Data are mean ± SEM
(bars) values for four or five separate experiments. *p < 0.05,
different from the control (— nigericin); °°p< 0.05, different from
142 mM K~,pH 7.4; ***p <0.05, different from the correspond-
ing control (— nigericin).
mOsm). The inhibitory effects of hypertonicity on
mAChR sequestrationwere readily reversible.Thus,
when cells that had beenpreincubatedin hypertonic
buffer A for 20 mm weretransferredto isotonicbuffer
A for 30 mm, theextentof agonist-induced mAChR
sequestrationwas comparableto thatobservedfor cells
incubatedcontinuouslyin isotonic buffer A (29 ± 4
vs. 31 ±4%, respectively;n = 3; Fig. 3B).
Depletion of K T~or acidification of the cytosol
inhibits mAChR sequestration
Nigericin, an ionophorethat promoteselectroneutral
K~/HTexchange,haspreviouslybeenusedto manip-
ulate [K~I~ (Larkin et al., 1985)andcytoplasmicpH
(HansenCt a!., 1993). Incubationof SH-SY5Y cells
in bufferA containing 5 or 10 mM KT in thepresence
of 4 ,uM nigericin resultedin >80% inhibition of
mAChR sequestration(Fig. 4A). Underthesecondi-
tions, the KT content of the cells wasreducedby
>85% (2.53±0.3 and0.32±0.07 j.tEq/mgof protein
in the absenceandpresenceof nigericin,respectively;
n = 4). When the extracellular[K + I was increased
to 142 mM (a concentrationthat approximatesthe
intracellularconcentrationof the cation), inclusionof
nigericin hadno effect on the extent of the Oxo-M-
inducedloss of [3HINMS binding sites.Undercondi-
tions in which the [K4 I is equivalenton both sides of
theplasmamembrane,nigericin canbe usedto clamp
theintracellularp1-I at the pHof theextracellularbuffer
(Thomaset al., 1979). When SH-SY5Y cells were
incubatedwith 4 p.M nigericin in the presenceof 142
mM K ~ but atareducedpH (6.0), mAChR sequestra-
tion wasinhibited by >85% (Fig. 4A). Incubationof
SH-SY5Ycells at pH 6.0, in the absenceof nigericin,
did not inhibit mAChR sequestration.Direct measure-
ment of the cytoplasmic pH revealedthat the latter
was reducedfrom 7.5 to 6.4 under theseconditions.
Depletion ofKT, had little or no effect on mAChR-
stimulatedinositol lipid hydrolysis as monitored by
eithertheaccumulationof 3H-IPTor 1(1 ,4,5) P
3 forma-
tion (Figs. 4B and5A), whereasan increasein both
basalandOxo-M-stimulated[Ca
2T]j wasob rvedun-
der theseconditions (Fig. SB). In contrast,acidifica-
tion of the cytosol resultedin a significant inhibition
(—~4S%)of Oxo-M stimulated 3H-IPT formation
(Fig. 4B).
Agonist-induced subcellular redistribution of cell
surface mAChRs under conditions of
hypertonicity or depletion of K~
The agonist-inducedredistribution of cell surface
mAChRs in SH-SY5Y cells, and its modulation by
hypertonicityanddepletionof K ~ wasalso monitored
by meansof subcellular fractionation.In preliminary
studies, anOxo-M-inducedredistributionof mAChRs
from a denseto less densefraction [35/60% to0/
35% sucroseinterfaces(seeLohse etal., 1990)] was
observed when cellysateswere subjectedto sucrose
densitygradientfractionation.However, because ofthe
limited degreeof enrichmentof mAChRs in this less




FIG. 5. Effect of depletion of K ‘jon (A) basal and Oxo-M-stimu-
lated l(1,4,5)P3 formation and (B) basal and Oxo-M-stimulated
rise in [Ca
2~],.SH-SY5Y cells were premncubated in buffer A(5.6
mM K4) for 20 mm at 37°Cin eitherthe absence (LI) or presence
(tI) of 4 jiM nigericin. After preincubation, Oxo-M was added
(final concentration, 1 mM), and reactions were allowed to pro-
ceed for a further 10 s for l(1,4,5)P
3 determination or 10—15 s
to monitor the maximal rise in [Ca
2~],.Data are mean ± SEM
(bars) values (n = 4 and 15 for I(1,4,5)P
3 level and [Ca
2~],
measurements, respectively). *p < 0.05, different from the con-
trol (— nigericin).
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TABLE 1. Subcellulardistribution of mAChRsin contro1 andOxo-M-stimulated cells
P
1 VI
tntactcells (30,000gilD mm) (200,000g/90 mm)
Control
[
3H]QNB binding: specific activity (fmol/mg of protein) 333 ± 34 859 ± 96 88 ± 33
Distribution of recovered[3HIQNBsites (%) (100) 95 ± 7 5 ± I
13H]NMS binding: specific activity (fmol/mg of protein) 339 ± 41 826 ± III 42 ± II”
Distribution of recovered[3H]NMSsites (%) (100) 97 ± 5 3 ±0”
Distribution of cellular protein (%) (100) 35 ± 6 19 ± 3
Oxo-M
[3H]QNB binding: specific activity (fmol/mg of protein) 306 ± 33” 704 ± 94” 352 ±77”
Distribution of recovered[3H]QNB sites (%) (100) 79 ± 7” 21 ± 3”
[3H]NMS binding: specific activity (fmolimg of protein) 201 ± 23” 573 ± 84” 85 ±20”
Distribution of recovered[3H]NMS sites(%) (100) 93 ± 5” 7 ± 1°”
Distribution of cellular protein(%) (100) 30 ± 6 19 ± 2
SH-SY5Ycells were incubatedin the absenceor presenceof 1 mM Oxo-M for 30 mm and then hypotonically lysed,
and crudeplasmamembrane(P
1) and “light” membrane(V1) fractionswere obtainedby differential centrifugation,as
describedin Materialsand Methods.Intact cells andP1 andV, fractionswereassayedfor [
3H]QNBor [3H]NMS binding
andfor protein content.The concentrationsof both radioligandswere sufficient to occupy >90% of mAChRsites in the
subcellularfractions.Data are mean± SEM valuesfor five to sevenseparateexperiments.The overall recoveriesof
[3H]QNBand I3HINMS binding sitesrangedfrom 77 to 87%. Approximately 40% of the cellularprotein wasrecovered
in the supernatants.
Different from [3H]QNB binding data,p < 0.05.
“Different from controlcell binding data,p < 0.05 (matched-pairanalysis).
“light membrane”(V
1) fractionswere isolated from
hypotonic lysatesof SH-SY5Y cells by meansof dif-
ferentialcentrifugation(Table 1). In controlcells,95—
97%of mAChRswere recoveredin theP1 fraction and
only 3—5% of receptorsin the V1 fraction. Whereas
[
3HIQNB and [3HINMS labeledthesamenumberof
bindingsitesin boththe intactcells andthe P
1 fraction,
consistentlymore mAChR sites were labeledby the
lipophilic antagonist[
3HIQNB in theV fraction than
by thehydrophilic antagonist,[3HINMS (p < 0.05).
WhenSH-SY5Y cells were incubatedin the presence
of 1 mM Oxo-M for 30 mm, the distribution of
mAChRs was altered such that receptordensity was
reducedin both intact cells and P
1 fractions,but the
effect wasmore pronouncedfor [
3H]NMS (31—41%)
than for [3H]QNB binding (8—18%). Conversely,a
markedincreasein mAChR density wasobservedfor
the V
1 fraction, such that after a 30-mm exposureof
SH-SY5Y cells to Oxo-M, the number of [
3H1QNB
binding sites rec vered in t is fraction increasedto
420%of control values.This translocationof mAChRs
could be blockedby prior incubationof the cells with
5 pM NMS (Fig. 6). As observedfor control cells,
mAChRspresentin the 1 fractionobtainedfromOxo-
M-treatedcellsweremuchlessaccessibleto thehydro-
philic ligand [3HINMS (233% of control), and no
further increasein the number of [3HINMS binding
sites could be obtained when the assayswere con-
ductedateitherhigherligand concentrationsor at37°C
(data not shown). BecauseSH-SYSY cells express
predominantly(but not exclusively)mAChRs of the
m
3 subtype(Slowiejko etal., 1994),immunoprecipita-
tion studieswere conductedon the V1 fraction.Anti-
serato the m3, m2, and m1 mAChRs precipitated77
± 11,20± 10, and 3 ± 3% of binding sites (n = 3).
These results indicate that on agonist addition, m3
mAChRsundergoendocytosisandareincreasinglyre-
coveredin a “light” membranefraction.The mAChRs
in this fraction arereadilydetectedby lipophilic antag-
onists such as [




1 fraction wasmarkedly inhibited (>85%) when
SH-SYSY cells wereincubatedunderhypertoniccon-
ditions.The inhibitory effectof hypertonicitycould be
reversedif cellspretreatedunderhypertonicconditions
were transferredto isotonic buffer A before addition
of Oxo-M (Fig. 6). Depletion of K
T, also inhibited
the redistribution of mAChRs by >85%. When SH-
SY5Y cells were incubatedwith pilocarpmne,a partial
muscarinicagonist,fewer[3H ] QNB bindingsiteswere
recoveredin the V
1 fraction than were observedfor
Oxo-M (159vs. 420%of controlvalues,respectively),
a result consistentwith the limited ability of this ago-
nist to promotea loss of [
3HINMS sites (Thompson
andFisher, 1990; Slowiejko et al., 1994) (Fig. 6).
Cellular redistribution of clathrin in SH-SY5Y
cells in responseto hypertonicity, depletion of
K ~ or acidification of cytosol
Indirect immunofluorescencetogetherwith conven-
tional and confocal microscopy was used to confirm
that the experimentalconditionschosen,i.e., hyperto-
nicity, depletionof KT~,or acidificationof cytosolhad
resulted in a cellular redistributionof clathrin in SH-
SYSY cells. Anti-clathrin immunofluorescencein con-
trol cells appearedto be distributed throughout the
cytoplasmin a punctatemanner,with someaccumula-
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FIG. 6. Effect of hypertonicity and depletion of K’, on the sub-
cellular redistribution of mAChRs. SH-SY5Y cells were first incu-
bated with either buffer A (control) or 1 mMOxo-M or pilocarpine
(Pilo) for 30 mm at 37°C. Cells were then hypotonically lysed,
and ‘V1’fractions were obtained by means of subcellular fraction-
ation, as described in Materials and Methods. The density of
mAChRs in V1 fractions was then determined by means of [
3H]-
QNB binding. In some experiments, SH-SY5Y cells were either
premncubated with 5 jiM NMS or, alternatively, subjected to con-
ditions of hypertonicity or depletion of K1,, before addition of
Oxo-M (for details, see legends to Figs. 3 and 4). Results are
expressed as specific binding relative to controls that were incu-
bated in the absence of agonist. Neither hypertonicity nor deple-
tion of K~,had any significant effect on [3H]QNBbinding in V
1
fractions obtained from control cells. The ability of NMS preincu-
bation to reduce [
3H]QNBbinding to below control levels may
reflect the ability of the antagonist to inhibit constitutive cycling
of mAChRs. Data are mean ± SEM (bars) values for three to
eight separate experiments. °p< 0.05, different from Oxo-M
alone.
tion in theperinuclearregion (Fig.7A). The presence
of clathrin at theplasma membrane itselfwasdifficult
to resolveconsistentlyowing toalow steady-statecon-
centration. Little or no immunofluorescence wasob-
servedwhencells wereincubatedwith mousenonspe-
cific IgG (Fig. 7B). Under hyperosmolarconditions,
theperinuclearaccumulationof clathrin was markedly
enhanced,and this was accompaniedby an apparent
reductionin theamountof c!athrinpresentin thecyto-
plasm.This patternof clathrin redistributionis consis-
tent with previousstudiesof nonneuralcells (Doxsey
et a!., 1987; Heuser andAnderson, 1989; Hansenet
al., 1993)andhasbeeninterpretedto indicateadisrup-
tion of theassemblyof clathrin-coatedpits. The redis-
tribution of clathrin from cytosol to perinuclearregion
observedunderhyperosmolar conditionswasreversed
when cells were returnedto isotonic buffer A (Fig.
7D). Increased immunostainingof clathrin in thepen-
nuclear regionwas also observedin cells depletedof
K~,(Fig. 7E). Under conditionsin which thecytosol
wasacidified, anincreasedoccurrenceof microaggre-
gatesof clathrin throughoutthe cytoplasm and atthe
plasmamembrane wasapparent(Fig. 7F). However,
in contrast to the redistribution pattern observedfor
hypertonicity and depletion of ~ an accumulation
of clathrin in theperinuclearregionwas not observed
when thecytosolwas acidified. Thispatternof immu-
nostainingis consistentwith the known abilityof re-
ducedpH toinhibit thebuddingof clathrin-coatedvesi-
desfrom theplasma membrane(Sandviget a!.,1987).
None of the threeexperimental proceduresadversely
affectedthemorphology ofSH-SY5Y cells.
Neither activation of protein kinase C nor




of mAChRswas investigatedby monitoring the extent
of loss of [3H]NMS binding sites after activation of
protein kinase C or following the perturbation of
plasma membranecholesterol. Under the latter two
conditions, the functioning of caveolaeis reportedto
be inhibited (Rothberg etal., 1990; Schnitzer et a!.,
1994; Smartet al., 1994).Preincubationof SH-SY5Y
cells with 1 pM PMA before addition ofOxo-M had
little or no effecton theextentof mAChRsequestration
(35 ±2 vs. 29±4% lossof [3H]NMS sites for control
and PMA-treatedcells, respectively; n = 5—9). In
contrast,Oxo-M-stimu!ated3H-IPT formation was in-
hibited by ~=50%by PMA (datanot shown). Over-
night incubation of the cells with 1 pM PMA also
failed to modulatethe extent of mAChR internaliza-
tion. Neitherpreincubationof SH-SY5Y cells withdig-
itonin,a steroidglycosidethat targetstheplasmamem-
brane owing toits high cholesterolcontent, nor the
addition of nystatin,a polyene antibiotic that binds
cholesterol,significantly reducedthemagnitudeof loss
of [3H] NMS binding sites following Oxo-M addition





ization basedon the repeated demonstrationthat the
endocytosisof receptor-specificligands is markedly
inhibited when cells are incubatedunderconditions
of hypertonicity, depletion of K T~, or acidification of
cytosol. By applicationof oneor more of thesecondi-
tions, a clathrin-mediatedmechanismhas previously
been identified for the endocytosis ofconstitutively
activereceptors,e.g., transferrin,low-density lipopro-
tein, or asialoglycoprotein(Larkin et a!., 1986; Sand-
vig eta!., 1987;Okaeta!., 1989)andfor theepidermal
growth factor receptor (Sandvig eta!., 1987). Al -
though less extensivelystudied,a role for c!athrin in
the endocytosis of,8
2-adrenergic receptors andm4
mAChRs has beenproposedbasedon inhibition by
hypertonicity anddepletion of K ~ respectively(Yu
etal.,1993;Ma!oteaux andHermans,1994). However,
whetherPLC-linked receptorsare endocytosedin a
similar manneris currently unknown. In the present
study,evidenceis presented thatall threeexperimental
conditions,namely, hypertonicity,depletionof ~ or
J. Neurochem.,Vol. 66, No. 1, /996
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FIG. 7. Indirect immunofluorescence localization of clathrmn in human neuroblastoma cells viewed by confocal microscopy. In control
experiments, SH-SY5Y cells were incubated for 20 mm at 37°Cin buffer A before formaldehyde fixation, permeabilization, and incubation
with either monoclonal anticlathrin IgG (X-22; 5 pg/mI; A) or mouse nonspecific lgG (from Vector Laboratories; 5 pg/mI; B), respectively.
Note the punctate distribution of clathrin throughout the cytoplasm and accumulation in the perinuclear region in A. C: Redistribution
of clathrin following a 20-mm incubation in buffer A made hypertonic with sucrose (550 mOsm). Enhanced accumulation of clathrin
in the permnuclear region of the cell is indicated by the arrow. D: Reversibility of effect when hypertonically treated SH-SY5Y cells were
transferred to isotonic buffer A for 30 mm before fixation. E: Cells depleted of K , by incubation with 4 p.M nigericmn for 40 mm in the
presence of 5.5 mM K*. Note the enhanced accumulation of clathrin in the permnuclear region, as indicated by the arrows. F: Cells
acidified by incubation with 4 p.M nigericin for 10 mm at 37°Cin the presence of 142 mM K (pH 6.0). Aggregation of clathrin is
indicated by the arrow. Shown are confocal images of 1-p.m optical slices taken midway through the cell(s). Bar in A = 25 jim.
acidification ofthecytosol result in amarkedattenua-
tion of theinternalizationof them3 mAChRs,a phos-
phoinositide-linkedreceptor.Agonist-inducedseques-
tration of mAChRs in SH-SY5Y cells was inhibited
in proportionto the degreeof hyperosmolanity,with
maximal inhibition observedat ‘=600 mOsm, avalue
similar to that necessaryfor complete inhibition of
transferrin endocytosisin reticu!ocytes (Bowen and
Morgan, 1988).Furthermore, inhibition of mAChR
sequestration,like that of transferrin endocytosis,
could bereversedwhencells werereturnedto an iso-
tonic medium.incubationof SH-SYSYcells with ni-
gericin, in thepresenceof low concentrationsof extra-
cellular K
T (5—10 mM), resulted in a marked
(>85%) inhibition of mAChR sequestration.That this
inhibition resultedfrom a depletionof K*~canbe in-
ferred from thereduction in ‘ contentof cells incu-
batedin thepresenceof nigericin andfrom theinability
of the ionophore to inhibit sequestrationwhen intra-
and extracellularconcentrations ofK + approximated
eachother.Whennigericinwasusedto lower cytosolic
pH to that of the extracellularbuffer (6.0), agonist-
inducedmAChR sequestrationwas also markedlyin-
hibited. Taken collectively,theseresults indicatethat
when clathnindistribution is disrupted,theinternaliza-
tion of mAChRs is concurrently inhibited.
A redistribution of clathrin in SH-SYSY cells,as
determinedby indirect immunofluorescence,accompa-
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nied the reductions in agonist-inducedsequestration.
Thus, in controlSH-SY5Ycells,apunctatedistribution
of clathrin was observedthroughout the cytoplasm,
with someaccumulationin the peninuclearregion of
the cell. Hypertonicity and depletion of ~ resulted
in a more pronouncedaccumulationof c!athrin in the
perinuclearregion with a reduction in clathnin immu-
noreactivityin thecytoplasm.This distribution pattern
observedfor clathrin in SH-SY5Ycells undercontrol
and experimentalconditions was similar to that ob-
tainedpreviously for nonneuralcells (Doxsey et al.,
1987; Heuser and Anderson, 1989; Hansenet a!.,
1993). Clathrin-coatedvesicles,which are formed at
both the plasmamembraneand trans-Go!gi network,
derive from acommonpool of cytosolic clathnin(Pley
andParham,1993). The increasedimmunostainingof
clathrin in theperinuclearregion of SH-SY5Y cells
underconditionsof hypertonicity or depletionof KT,
is consistentwith an accumulationof clathrin-coated
vesiclesin the trans-Go!ginetwork. This, in turn, may
result in a reduction in the availability of clathrin for
assemblyinto clathrin-coatedpits at theplasmamem-
brane.In contrast,whenthecytosolwasacidified,there
was an appearanceof microaggregatesof clathrin
within thecytoplasmand at thecell surface,but little
or no increasedperinuclearstainingwasobserved.This
patternof immunostainingis consistentwith theknown
ability of acidificationof thecytosol to inhibit thebud-
ding of clathnin-coatedpits (Sandviget al., 1987).
Although mAChR sequestrationwasattenuatedun-
derconditionsof hypertonicity,depletionof K”1, or
acidification of cytosol, no comparableinhibition of
theagonist-mediatedgenerationof inositol phosphates
and rise in [Ca
2”]
1 was observed.In addition, given
thatcell surfaceratherthan internalizedmAChRspref-
erentially couple to PLC activation (Thompson and
Fisher, l991), it should be noted that inhibition of
mAChR sequestrationwas not accompaniedby any
measurableincreasein theextentof phosphoinositide
hydrolysis.The latter result indicatesthat the number
of mAChRspresentat theplasmamembraneis not the
soledeterminantof themagnitudeof stimulatedinosi-
tol lipid turnover(seeFisheret al., 1994).The failure
of hypertonicity and depletion of K~1to affect ad-
verselyPLC activationexcludesthepossibility that the
inhibition of mAChR sequestrationresultsfrom either
nonspecific interferencewith receptor—ligandinterac-
tions or, alternatively, is due to cell toxicity. Of the
threeexperimentalparadigmsused,only acidification
of the cytosol resulted in a significant inhibition of
stimulated phosphoinositidehydrolysis, a result that
may reflectthepHoptimumof PLC (Rheeetal., 1989)
or a reduction in ATP availability (Sandvig et al.,
1987). However, even undertheseconditions,stimu-
lated inositol lipid hydrolysis was less inhibited than
mAChR internalization. Other studieshave indicated
that the experimental procedures used to perturb
clathrin distribution do not inhibit fluid-phaseendocy-
tosis (DaukasandZigmond, 1985;HeuserandAnder-
son, 1989;Oka et a!., 1989) or endocytosismediated
via non—clathrin-coated membrane invaginations
(Roettgeret al., 1995).
Although it hasbeenproposedthatreceptorseques-
tration may representan altered conformationof the
receptorwithin the plasmamembrane(Wang et al.,
1989), two lines of evidencesupport theconceptthat
mAChRs in SH-SY5Y cells undergo endocytosis.
First, on agonistaddition,mAChRsare recoveredin a
“light” membranefraction, distinct from that of the
plasmamembrane,whenlysatesof SH-SY5Y cells are
subjectedto subcel!ularfractionation.It is likely that
this fraction representsan “endosomal” compartment
of the cell that in part, at least,may be derivedfrom
vesicles from which the clathrin coat haspreviously
beenremoved.Thus, mAChRsthat mayinitially enter
the cell via clathrin-coatedpits are recoveredin this
fraction on prolongedagonistexposure.ThemAChRs
in this fraction are accessibleto lipophilic, but not
hydrophilic, ligands, suggestingthat they are present
in endocytic“inside-out” vesicles.This redistribution
of receptorscanbeblocked by hypertonicityor deple-
tion of K’~.Second,in digitonin-permeabilizedcells,
the sequesteredmAChRs also remaininaccessibleto
thehydrophilic ligands, evenunderconditions of pro-
longedincubation.Only whentheconcentrationof dig-
itonin is further increasedarethese“occluded” recep-
tor sites unmasked(Slowiejko et al., 1994). Taken
collectively, these results and those obtained under
conditions in which c!athrin distribution is perturbed
suggest that on agonist addition, mAChRs in SH-
SY5Y cells undergoendocytosisvia a clathnin-medi-
atedprocess.However, conclusiveproof of suchwill
necessitatethe direct demonstrationof mAChRs in
clathrin-coatedpits. In this regard,it is relevantto note
that the presenceof mAChRs in a brain subcellular
fraction enrichedin clathrin-coatedvesicleshaspre-
viously beendocumented(Silva et a!., 1986). In addi-
tion, GABAA/benzodiazepinereceptorshavealsobeen
localized to clathrin-coated vesicles (Tehrani and
Barnes, 1993). Based on immunocytochemicalevi-
dence,a role for clathrin in the internalizationof sub-
stanceP receptors(which coupleto phosphoinositide
turnover)hasalso recentlybeenproposed(Garlandet
a!., 1994). Thus, it is conceivablethat aninvolvement
of clathninin theendocytosisof PLC-linked receptors
may be widespread.
Recently,arolefor caveolaein cell signaling events




receptorprotein, and the endothelinreceptorto these
structures (Fujimoto, 1993; Fujimoto et al., 1993;
Chunet a!., 1994). However,a majorinvolvementof
caveolaein the internalization of mAChRs in SH-
SY5Y cells appearsunlikely for thefollowing reasons.
First, cholesterolperturbationandactivationof protein
kinase C, both of which have beendemonstratedto
interfere with the structureand function of caveolae
(Rothberget a!., 1990; Schnitzeret a!., 1994; Smart
j. Neurochem.,Vol. 66, No. 1, /996
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et al., 1994), hadno effecton theOxo-M-inducedloss
of [3H I NMS sites. Second,caveolaeare reportedtobe unaffectedby hypertonicity and depletionof KT~
(Roettger et a!., 1995), conditions under which
mAChR sequestrationis blocked.
In summary,the agonist-inducedinternalizationof
mAChRsin SH-SY5Y neuroblastomais inhibited un-
der conditions in which clathrin distribution is per-
turbed.Theseresultsareconsistentwith theoccurrence
of aclathnin-mediatedendocytosisof mAChRsin these
cells.
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